Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
2022 · Cell Reports · 72 citations
https://doi.org/10.1016/j.celrep.2022.111162
J
Jack Goddard
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
125
Citations
5
h-index
4
i10-index
Jack Goddard is an academic researcher from Newcastle University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & MicroRNA in disease regulation & Lymphoma Diagnosis and Treatment. The author has an h-index of 5, co-authored 12 publications.
ORCID: 0000-0001-9374-6036Papers by this author
worksIbrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
2023 · Blood Advances · 16 citations
https://doi.org/10.1182/bloodadvances.2023011152
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
2023 · Acta Neuropathologica · 12 citations
https://doi.org/10.1007/s00401-023-02566-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat